Literature DB >> 17540588

Medical management of abdominal aortic aneurysm.

J Golledge1, J T Powell.   

Abstract

Medical management of patients with abdominal aortic aneurysm (AAA) is required for several different reasons. Since these patients have an increased risk of cardiovascular death therapy to reduce cardiovascular events is essential. Treatment is in line with the medical management of coronary artery disease including smoking cessation, statins and anti-platelet therapy. Some of these therapies also will slow aneurysm growth. Currently there is no proven focused therapy that reduces aneurysm growth, but the emerging strategies are discussed. Medical management also is required to reduce peri-operative risks and stabilise endovascular aneurysm repair. Whilst some of the therapies targeting cardiovascular risk reduction may be helpful, other emerging strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540588     DOI: 10.1016/j.ejvs.2007.03.006

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  10 in total

Review 1.  Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.

Authors:  Ahmed Klink; Fabien Hyafil; James Rudd; Peter Faries; Valentin Fuster; Ziad Mallat; Olivier Meilhac; Willem J M Mulder; Jean-Baptiste Michel; Francesco Ramirez; Gert Storm; Robert Thompson; Irene C Turnbull; Jesus Egido; Jose L Martín-Ventura; Carlos Zaragoza; Didier Letourneur; Zahi A Fayad
Journal:  Nat Rev Cardiol       Date:  2011-02-08       Impact factor: 32.419

Review 2.  Targeting Platelet Activation in Abdominal Aortic Aneurysm: Current Knowledge and Perspectives.

Authors:  Weiliang Sun; Jingang Zheng; Yanxiang Gao
Journal:  Biomolecules       Date:  2022-01-25

3.  Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression.

Authors:  Maureen M Tedesco; Masahiro Terashima; Francis G Blankenberg; Zoia Levashova; Joshua M Spin; Marina V Backer; Joseph M Backer; Mien Sho; Eiketsu Sho; Michael V McConnell; Ronald L Dalman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-02       Impact factor: 8.311

4.  Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation.

Authors:  Nicholas J Leeper; Maureen M Tedesco; Yoko Kojima; Geoffrey M Schultz; Ramendra K Kundu; Euan A Ashley; Phillip S Tsao; Ronald L Dalman; Thomas Quertermous
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-20       Impact factor: 4.733

5.  Gaining new insights into early abdominal aortic aneurysm disease.

Authors:  Julie J White; Ronald L Dalman
Journal:  Perm J       Date:  2008

6.  Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue.

Authors:  Koichi Yoshimura; Ayako Nagasawa; Junichi Kudo; Masahiko Onoda; Noriyasu Morikage; Akira Furutani; Hiroki Aoki; Kimikazu Hamano
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

Review 7.  Current Status and Perspectives on Pharmacologic Therapy for Abdominal Aortic Aneurysm.

Authors:  Koichi Yoshimura; Noriyasu Morikage; Shizuka Nishino-Fujimoto; Akira Furutani; Bungo Shirasawa; Kimikazu Hamano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

8.  Recent advances in pharmacotherapy development for abdominal aortic aneurysm.

Authors:  Koichi Yoshimura; Hiroki Aoki
Journal:  Int J Vasc Med       Date:  2012-08-21

9.  Periostin links mechanical strain to inflammation in abdominal aortic aneurysm.

Authors:  Osamu Yamashita; Koichi Yoshimura; Ayako Nagasawa; Koshiro Ueda; Noriyasu Morikage; Yasuhiro Ikeda; Kimikazu Hamano
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

Review 10.  Abdominal Aortic Aneurysm: Roles of Inflammatory Cells.

Authors:  Zhen Yuan; Yi Lu; Jia Wei; Jiaqi Wu; Jin Yang; Zhejun Cai
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.